All posts by: Michael Zand

About Michael Zand

California stem cell agency eyes human gene editing – Capitol Weekly

Continue reading

2016-01-28

Capitol Weekly

California stem cell agency eyes human gene editing
Capitol Weekly
The $3 billion California stem cell agency next Thursday will convene a day-long examination of human gene editing, a field that could be a “gold mine for biotechnology” and perhaps alter the human race permanently. “Easy DNA Editing Will Remake the …

Continue reading

2016-01-28

Human Longevity Acquires Stem Cell Banking Business Unit from Celgene
GenomeWeb
As part of the deal, HLI will receive LifebankUSA’s proprietary method for high-yield extraction of placental stem cells — this process yields 60 percent to 70 percent more of CD34+ stem cells, which are critical for bone marrow and cord blood
Human Longevity Inc. Advances Leadership Role in Newborn Genome Sequencing with Strategic Acquisition of Stem PR Newswire (press release)
Human Longevity Acquires LifebankUSA, Biomaterials Business from CelgeneGenetic Engineering & Biotechnology News (blog)

all 3 news articles »

Continue reading

2016-01-28

Mouse chimeras for testing human stem cell pluripotency
Nature.com
Human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) are considered pluripotent because of their ability to differentiate into most embryonic cell types in vitro. But a more stringent test for pluripotency—the ability

Continue reading

2016-01-28

Only 4 licensed stem cell facilities in PH – DOH
Manila Bulletin
There are only four accredited health facilities in the country duly authorized and licensed to provide stem cell services, the Department of Health (DOH) announced yesterday. Stem cell therapy is a type of intervention strategy that introduces new
DOH approves first gov’t hospital for stem cell servicesSun.Star
4 facilities OK’d for stem cell treatmentMalaya
6 million euro Galway project to develop new stem cell technologyConnacht Tribune Group

all 4 news articles »